APDN (Applied DNA Sciences) Market Cap : $2.02 Mil (As of Mar. 18, 2025)

View and export this data going back to 2001. Start your Free Trial

What is Applied DNA Sciences Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Applied DNA Sciences's share price for the quarter that ended in Dec. 2024 was $10.2. Applied DNA Sciences's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 1.08 Mil. Therefore, Applied DNA Sciences's market cap for the quarter that ended in Dec. 2024 was $11.04 Mil.

Applied DNA Sciences's quarterly market cap increased from Jun. 2024 ($4.21 Mil) to Sep. 2024 ($6.69 Mil) and increased from Sep. 2024 ($6.69 Mil) to Dec. 2024 ($11.04 Mil).

Applied DNA Sciences's annual market cap increased from Sep. 2022 ($14.69 Mil) to Sep. 2023 ($16.94 Mil) but then declined from Sep. 2023 ($16.94 Mil) to Sep. 2024 ($6.69 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Applied DNA Sciences's Enterprise Value for Today is $-6.40 Mil.

Applied DNA Sciences Market Cap Historical Data

The historical data trend for Applied DNA Sciences's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied DNA Sciences Market Cap Chart

Applied DNA Sciences Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Market Cap

Get a 7-Day Free Trial

38.65

37.73

14.69

16.94

6.69

Applied DNA Sciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Market Cap	Get a 7-Day Free Trial															8.64	6.97	4.21	6.69	11.04

Competitive Comparison of Applied DNA Sciences's Market Cap

For the Diagnostics & Research subindustry, Applied DNA Sciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Applied DNA Sciences's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Applied DNA Sciences's Market Cap distribution charts can be found below:

* The bar in red indicates where Applied DNA Sciences's Market Cap falls into.

Applied DNA Sciences Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Applied DNA Sciences's Market Cap for the fiscal year that ended in Sep. 2024 is calculated as

Market Cap (A: Sep. 2024 )	=	Share Price (A: Sep. 2024 )	*	Shares Outstanding (EOP) (A: Sep. 2024 )
	=	$32.485	*	0.206
	=	$6.69

Applied DNA Sciences's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )	=	Share Price (Q: Dec. 2024 )	*	Shares Outstanding (EOP) (Q: Dec. 2024 )
	=	$10.2	*	1.082
	=	$11.04

Applied DNA Sciences (NAS:APDN) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Applied DNA Sciences Market Cap Related Terms

Thank you for viewing the detailed overview of Applied DNA Sciences's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Applied DNA Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Applied DNA Sciences Inc (NAS:APDN) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 Health Sciences Drive, Stony Brook, New York, NY, USA, 11790

Website

https://www.adnas.com

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Executives

Clay Shorrock	officer: Chief Legal Officer	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Scott L Anchin	director	16990 GOLDENTOP ROAD, SUITE A, SAN DIEGO CA 92127
William W Montgomery	10 percent owner	34211 SEAVEY LOOP RD., EUGENE OR 97405
Judith Murrah	officer: Chief Information Officer	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Beth Jantzen	officer: Chief Financial Officer	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Yacov A Shamash	director
Robert B Catell	director	62 OSBORNE ROAD, GARDEN CITY NY 11530
John Iii Bitzer	director	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Joseph D. Ceccoli	director	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Elizabeth M. Ferguson	director	50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Charles S. Ryan	director	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
James A Hayward	director, officer: Chief Executive Officer	C/O 25 HEALTH SCIENCES DRIVE, SUITE 113, NEW YORK NY 11790
Karol Gray	officer: Chief Financial Officer	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Ming-hwa Benjamin Liang	officer: Strategic Tech. Dev. Officer	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Yacov Shamash	director	100 ENGINEERING, STATE UNIVERSITY OF NY, STONE BROOK NY 117942200